Charles Schwab
NBP

Charles Schwab’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Charles Schwab’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-75,469
Closed -$853K – 3529
2022
Q2 		$853K Buy
75,469
+41,743
+124% +$500K ﹤0.01% 2854
2022
Q1 		$548K Buy
33,726
+1,370
+4% +$35.1K ﹤0.01% 3072
2021
Q4 		$1.53M Sell
32,356
-2,504
-7% -$150K ﹤0.01% 2780
2021
Q3 		$2.53M Buy
+34,860
New +$2.52M ﹤0.01% 2646

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab's NBP Position: Q3 2022 in Review

Charles Schwab sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 75,469 shares — an estimated $853K sold.

Charles Schwab first reported a position in NBP in Q3 2021 and held it in 4 quarters. The position peaked at $2.53M in Q3 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Charles Schwab reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Charles Schwab sold 75,469 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $853K.
  • Charles Schwab first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 4 quarters.
  • Charles Schwab's NovaBridge Biosciences American Depositary Shares position peaked at $2.53M in Q3 2021.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.